Table 1 Basic characteristics
Control group count (% within groups) or median (IQR), n = 124 | Intervention group count (% within groups) or median (IQR), n = 114 | ||
|---|---|---|---|
Gender | |||
Male | 72 (58.1) | 59 (51.8) | p = 0.362 |
Female | 52 (41.9) | 55 (48.2) | |
Age (months) | |||
0–3 | 12 (9.7) | 19 (16.7) | p = 0.346 |
4–12 | 24 (19.4) | 28 (24.6) | |
13–24 | 22 (17.7) | 15 (13.2) | |
25–72 | 28 (22.6) | 23 (20.2) | |
≥73 | 38 (30.6) | 29 (25.4) | |
Weight (kg) | |||
<5 | 9 (7.3) | 11 (9.6) | p = 0.538 |
5–9.99 | 37 (29.8) | 41 (36.0) | |
10–19.99 | 38 (30.6) | 29 (25.4) | |
20–39.99 | 24 (19.4) | 24 (21.1) | |
≥40 | 16 (12.9) | 9 (7.9) | |
General anaesthetic (sevoflurane or N2O) | |||
No | 52 (41.9) | 41 (36.0) | p = 0.356 |
Yes | 72 (58.1) | 73 (64.0) | |
Local anaesthetic (EMLA®) | |||
No | 67 (54.0) | 39 (34.2) | p = 0.003 |
Yes | 57 (46.0) | 75 (65.8) | |
LA in >72 months | |||
No | 28 (73.7) | 6 (20.7) | p < 0.001 |
Yes | 10 (26.3) | 23 (79.3) | |
LA in ≤72 months | |||
No | 39 (45.3) | 33 (38.8) | p = 0.440 |
Yes | 47 (54.7) | 52 (61.2) | |
Size of needles (GA) | |||
26 | 0 (0) | 3 (2.6) | p = 0.069 |
24 | 59 (47.6) | 63 (55.3) | |
22 | 57 (46.0) | 38 (33.3) | |
20 | 8 (6.5) | 10 (8.8) | |